Resultados de la búsqueda 51-60 of 12606 for Cell membrane

1. Cirugía - Ensayos clínicos - Mayo Clinic

   Estimation of Biomechanical Aortic Wall Properties in Healthy and Aneurysmal Aortas Using Novel Imaging Techniques. Jacksonville, Fla. The primary aim of this ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... cells. Romidepsin and lenalidomide may stop the growth of cancer cells by blocking enzymes needed for cell growth. Giving rituximab together with romidepsin ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... wall circumference, and/or reconstructible occlusion of the SMV-PV. ... Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for ...

4. Cirugía - Ensayos clínicos - Mayo Clinic

   Estimation of Biomechanical Aortic Wall Properties in Healthy and Aneurysmal Aortas Using Novel Imaging Techniques. Jacksonville, Fla. The primary aim of this ...

5. Cirugía - Ensayos clínicos - Mayo Clinic

   The purpose of this study is evaluate the safety of allogeneic adipose derived mesenchymal stem cell ... wall and spinal deformities to develop a multicenter ...

6. Hematología - Ensayos clínicos - Mayo Clinic

   This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns of ...

7. Cirugía - Ensayos clínicos - Mayo Clinic

   Estimation of Biomechanical Aortic Wall Properties in Healthy and Aneurysmal Aortas Using Novel Imaging Techniques. Jacksonville, Fla. The primary aim of this ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...

9. Cirugía - Ensayos clínicos - Mayo Clinic

   Estimation of Biomechanical Aortic Wall Properties in Healthy and Aneurysmal Aortas Using Novel Imaging Techniques. Jacksonville, Fla. The primary aim of this ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...